LEADER 05528nam 2200673 450 001 9910131638203321 005 20230807221448.0 010 $a1-118-67485-5 010 $a1-118-67486-3 035 $a(CKB)3710000000460077 035 $a(EBL)1953181 035 $a(SSID)ssj0001551349 035 $a(PQKBManifestationID)16167719 035 $a(PQKBTitleCode)TC0001551349 035 $a(PQKBWorkID)14811718 035 $a(PQKB)11045463 035 $a(MiAaPQ)EBC4037419 035 $a(Au-PeEL)EBL4037419 035 $a(CaPaEBR)ebr11111713 035 $a(CaONFJC)MIL820104 035 $a(OCoLC)917551850 035 $a(EXLCZ)993710000000460077 100 $a20151105h20152015 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aBladder cancer $ediagnosis and clinical management /$fedited by Seth P. Lerner, Mark P. Schoenberg, Cora N. Sternberg ; contributors Hikmat Al-Ahmadie [and forty five others] 210 1$aChichester, England :$cWiley Blackwell,$d2015. 210 4$dİ2015 215 $a1 online resource (445 p.) 300 $aDescription based upon print version of record. 311 $a1-118-67484-7 311 $a1-118-67482-0 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aTitle Page; Copyright Page; Contents; List of contributors; Preface; Acknowledgments; Part I Diagnosis and treatment of non-muscle-invasive bladder cancer; Chapter 1 Pathology; Benign urothelium; Reactive urothelium; Urothelial hyperplasia; Urothelial dysplasia; Flat urothelial carcinoma in situ (CIS); Papillary lesions; Invasive urothelial carcinoma; Carcinomas with divergent (aberrant) differentiation; Squamous cell carcinoma; Adenocarcinoma; Small cell/neuroendocrine carcinoma; Nested variant of urothelial carcinoma; Lymphoepithelioma-like carcinoma; Micropapillary carcinoma 327 $aSarcomatoid carcinoma Useful web links; References; Chapter 2 Risk stratification of high-grade Ta, CIS, and T1 urothelial carcinoma of the bladder; Introduction; Risk stratification; Ta high-grade urothelial carcinoma of the bladder; Carcinoma in situ; T1 urothelial carcinoma of the bladder; Non-surgical treatment options for BCG failure; Early radical cystectomy; References; Chapter 3 Utility of urine biomarkers; Introduction; FDA-approved urine markers; Useful web links; Note; References; Chapter 4 Novel endoscopic techniques for the detection of bladder cancer; Photodynamic diagnosis (PDD) 327 $aNarrow band imaging Confocal laser endomicroscopy; Optical coherence tomography; Conclusions; Useful web link; References; Chapter 5 Transurethral resection of bladder tumors; Introduction; Endoscopy and visualization of the bladder; The first TURBT and the evolution of instrumentation; Patient preparation; Surgical technique; Special situations for TURBT; Efficacy of TURBT; Other techniques; Intravesical therapy; Radical TURBT and bladder-sparing for muscle-invasive disease; Conclusions; Useful web links; References; Chapter 6 Intravesical chemotherapy; Introduction 327 $aHistory of intravesical chemotherapy Intravesical chemotherapy; Treatment outcome; Complications/side effects; Device-assisted intravesical chemotherapy; Useful web links; Note; References; Chapter 7 Intravesical immunotherapy; Introduction; History/development; BCG mechanism of action; Induction; BCG and carcinoma in situ; BCG prevention of recurrence; BCG prevention of progression; BCG maintenance; BCG toxicity and treatment; Alternative forms of immunotherapy; Conclusion; Useful web links; References; Chapter 8 HGT1 bladder cancer: Diagnosis and treatment; Overview; Diagnosis; Follow-up 327 $aTreatment Useful web links; References; Chapter 9 What to do when bacillus Calmette-Gue?rin fails; Introduction; Definition of BCG failure; Treatment of BCG-refractory CIS; Conclusion; Useful web links; References; Part II T2-4; Chapter 10 Selection and perioperative management of patients undergoing radical cystectomy and urinary reconstruction; Introduction; Patient selection; Pre-operative preparation; Inpatient standardization and pathways (inpatient and beyond); Conclusions and future state - what do we need to work on?; Useful web links; References 327 $aChapter 11 Radical cystectomy: Techniques and outcomes 330 $aBladder Cancer: Diagnosis and Clinical Management is a 100% clinically-focused guide to bladder cancer, providing practical, modern and evidence-based guidance to the latest in diagnosis and management of the condition. It differs from other books in its complete clinical focus as opposed to a heavy analysis of pathogenesis or basic science. As a result, practicing urologists and oncologists in the clinical setting will find it an essential resource to consult. In addition to the latest in diagnostic tools and imaging methods, core focus is on the management of each form of cancer at its 606 $aBladder$xCancer$xTreatment 606 $aBladder$xCancer$xDiagnosis 615 0$aBladder$xCancer$xTreatment. 615 0$aBladder$xCancer$xDiagnosis. 676 $a616.99262 702 $aLerner$b Seth P. 702 $aSchoenberg$b Mark P. 702 $aSternberg$b Cora N. 702 $aAl-Ahmadie$b Hikmat 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910131638203321 996 $aBladder Cancer$92275341 997 $aUNINA